{"id": "1384566791905681408", "creation": 1618941421.0, "user_id": "17509945", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 3, "reply_count": 0, "like_count": 6, "quote_count": 0}}, "text": "Fewer than 40% of patients with chronic lymphocytic #leukemia had an adequate immune response to two doses of the Pfizer/BioNTech #COVID19 #vaccine, reported @herishanu, MD, in Blood. By @CBankheadMPT, @MedpageOnco. #leukSM #IDtwitter #onctwitter\nhttps://t.co/z3i15qbgmV", "first_save": 1634559108.199414, "hashtags": ["#LEUKEMIA", "#COVID19", "#VACCINE", "#LEUKSM", "#IDTWITTER", "#ONCTWITTER"]}